Christopher Mutz
Förmögenhet: 5 M $ per 2026-07-31
Förmögenhet: 5 M $ per 2026-07-31
Christopher K.
Mutz is Senior Vice President & Head-Rare Diseases at ANI Pharmaceuticals, Inc. since 2021.
Formerly, Mr. Mutz was National Sales Director-US Metabolic Business Unit at Alexion Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Virginia and an MBA from Johnson Graduate School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-16 | 62 245 ( 0,27 % ) | 5 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Företagsledare/Principal | 2021-02-17 |
| Företag | Position | Slut |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån